326 related articles for article (PubMed ID: 28526446)
1. Thymoquinone exerts neuroprotective effect in animal model of Parkinson's disease.
Ebrahimi SS; Oryan S; Izadpanah E; Hassanzadeh K
Toxicol Lett; 2017 Jul; 276():108-114. PubMed ID: 28526446
[TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins.
Rahimmi A; Khosrobakhsh F; Izadpanah E; Moloudi MR; Hassanzadeh K
Brain Res Bull; 2015 Apr; 113():34-40. PubMed ID: 25732239
[TBL] [Abstract][Full Text] [Related]
3. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
4. Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson's disease therapy.
Zaitone SA; Ahmed E; Elsherbiny NM; Mehanna ET; El-Kherbetawy MK; ElSayed MH; Alshareef DM; Moustafa YM
Pharmacol Rep; 2019 Feb; 71(1):32-41. PubMed ID: 30368226
[TBL] [Abstract][Full Text] [Related]
5. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
Alam M; Danysz W; Schmidt WJ; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous rotenone rat model of Parkinson's disease: Dose exploration study.
Zhang ZN; Zhang JS; Xiang J; Yu ZH; Zhang W; Cai M; Li XT; Wu T; Li WW; Cai DF
Brain Res; 2017 Jan; 1655():104-113. PubMed ID: 27876560
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats.
Teerapattarakan N; Benya-Aphikul H; Tansawat R; Wanakhachornkrai O; Tantisira MH; Rodsiri R
Phytomedicine; 2018 May; 44():65-73. PubMed ID: 29895494
[TBL] [Abstract][Full Text] [Related]
9. Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats.
Kandil EA; Abdelkader NF; El-Sayeh BM; Saleh S
Neuroscience; 2016 Sep; 332():26-37. PubMed ID: 27365173
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease.
Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
Drug Des Devel Ther; 2015; 9():5499-510. PubMed ID: 26504373
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death.
Grammatopoulos TN; Ahmadi F; Jones SM; Fariss MW; Weyhenmeyer JA; Zawada WM
Brain Res; 2005 May; 1045(1-2):64-71. PubMed ID: 15910763
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro.
Ardah MT; Merghani MM; Haque ME
Neurochem Int; 2019 Sep; 128():115-126. PubMed ID: 31028778
[TBL] [Abstract][Full Text] [Related]
14. The Protective Effect of Korean Red Ginseng Against Rotenone-Induced Parkinson's Disease in Rat Model: Modulation of Nuclear Factor-κβ and Caspase-3.
Zaafan MA; Abdelhamid AM; Ibrahim SM
Curr Pharm Biotechnol; 2019; 20(7):588-594. PubMed ID: 31198107
[TBL] [Abstract][Full Text] [Related]
15. Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.
Kikuchi Y; Yasuhara T; Agari T; Kondo A; Kuramoto S; Kameda M; Kadota T; Baba T; Tajiri N; Wang F; Tayra JT; Liang H; Miyoshi Y; Borlongan CV; Date I
J Cell Physiol; 2011 May; 226(5):1390-8. PubMed ID: 20945350
[TBL] [Abstract][Full Text] [Related]
16. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease.
Saravanan KS; Sindhu KM; Mohanakumar KP
Brain Res; 2005 Jul; 1049(2):147-55. PubMed ID: 15936733
[TBL] [Abstract][Full Text] [Related]
17. Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its neuroprotective activity and increased expression of tyrosine hydroxylase immunopositive cells.
Alabi AO; Ajayi AM; Ben-Azu B; Omorobge O; Umukoro S
Metab Brain Dis; 2019 Dec; 34(6):1723-1736. PubMed ID: 31463866
[TBL] [Abstract][Full Text] [Related]
18. Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents.
Garabadu D; Agrawal N
Neuromolecular Med; 2020 Jun; 22(2):314-330. PubMed ID: 31916219
[TBL] [Abstract][Full Text] [Related]
19. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
Testa CM; Sherer TB; Greenamyre JT
Brain Res Mol Brain Res; 2005 Mar; 134(1):109-18. PubMed ID: 15790535
[TBL] [Abstract][Full Text] [Related]
20. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Salama RM; Tadros MG; Schaalan MF; Bahaa N; Abdel-Tawab AM; Khalifa AE
J Cell Physiol; 2018 Aug; 233(8):5981-6000. PubMed ID: 29266208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]